These molecular subgroups of MB are characterized by a particularly aggressive tumor growth, with a five-year OS of 41% and 50%, respectively, frequent drop metastases to the leptomeningeal spaces, and high-level expression and amplification of MYC [1, 2, 25–29]. The gene discussed is MYC; the disease is neoplasm.